THE RELATIONSHIP OF PENTRAXIN-3 LEVELS IN BEHCET DISEASE WITH IL-17, DISEASE ACTIVITY AND ATHEROSCLEROTIC RISK FACTORS

被引：2
|
作者：
Sag, S. [1 ]
Kamanli, A. [1 ]
Tekeoglu, I. [1 ]
Nas, K. [1 ]
Sag, M. S. [1 ]
Harman, H. [2 ]
Altindis, M. [3 ]
机构：
[1] Sakarya Univ, Dept Phys Med & Rehabil, Fac Med, Rheumatol, Sakarya, Turkey
[2] Abant Izzet Baysal Univ, Dept Phys Med & Rehabil, Fac Med, Rheumatol, Bolu, Turkey
[3] Sakarya Univ, Dept Microbiol, Fac Med, Sakarya, Turkey
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.2003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0534
引用
收藏
页码：1087 / 1088
页数：2
相关论文
共 50 条
  • [31] Pentraxin-3 Serum Levels are Associated with Disease Severity and Mortality in Patients with Systemic Inflammatory Response Syndrome
    Bastrup-Birk, S.
    Skjoedt, M-O
    Munthe-Fog, L.
    Ma, Y. J.
    Garred, P.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2013, 77 (04) : 271 - 271
  • [32] Relationship between Th17 cell proportion and IL-17/-18 levels and disease progression in patients with multiple myeloma
    Liu, Wen
    Zhu, Jing
    Cheng, Jibing
    Tang, Qian
    Long, Siqi
    MOLECULAR & CELLULAR TOXICOLOGY, 2025, 21 (01) : 85 - 91
  • [33] Pentraxin-3 Serum Levels Are Associated with Disease Severity and Mortality in Patients with Systemic Inflammatory Response Syndrome
    Bastrup-Birk, Simone
    Skjoedt, Mikkel-Ole
    Munthe-Fog, Lea
    Strom, Jens J.
    Ma, Ying Jie
    Garred, Peter
    PLOS ONE, 2013, 8 (09):
  • [34] Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome
    Bastrup-Birk, S.
    Skjoedt, M-O
    Munthe-Fog, L.
    Ma, Y. J.
    Garred, P.
    MOLECULAR IMMUNOLOGY, 2013, 56 (03) : 287 - 287
  • [35] Risk factors of disease activity in patients with Behcet's syndrome
    Hou, Cheng-cheng
    Guan, Jian-long
    CLINICAL RHEUMATOLOGY, 2021, 40 (04) : 1465 - 1471
  • [36] The Relationship between Plasma Pentraxin 3 and Serum Amyloid P Levels and Disease Activity in Ankylosing Spondylitis
    Ozdemirel, Ali Erhan
    Guven, Serdar Can
    Sunar, Ismihan
    Surmeli, Zuhre Sari
    Doganci, Alper
    Tutkak, Huseyin
    Sayin, Ayse Peyman Yalcin
    Ataman, Sebnem
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2022, 2022 : 7243399
  • [37] Pentraxin 3 Plasma Levels and Disease Activity in Systemic Lupus Erythematosus
    Assandri, Roberto
    Monari, Marta
    Colombo, Anna
    Dossi, Alessandra
    Montanelli, Alessandro
    AUTOIMMUNE DISEASES, 2015, 2015
  • [38] Increased concentration of plasma pentraxin 3 levels in patients with systemic lupus erythematosus: Relationship to disease activity
    Asanuma, Yu
    Sato, Kojiro
    Ota, Muneo
    Sakamoto, Mayuko
    Shimada, Yuki
    Yamamoto, Akinori
    Nakajima, Kyoichi
    Akiyama, Yuji
    Mimura, Toshihide
    Isozaki, Mitsuhiro
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S572 - S572
  • [39] IFN-α blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease
    Liu, Xiaoli
    Yang, Peizeng
    Wang, Chaokui
    Li, Fuzhen
    Kijlstra, Aize
    RHEUMATOLOGY, 2011, 50 (02) : 293 - 298
  • [40] Predictive value of pentraxin-3 on disease severity and mortality risk in patients with hemorrhagic fever with renal syndrome
    Du, Hong
    Hu, Haifeng
    Wang, Pingzhong
    Wang, Xiaoyan
    Zhang, Ying
    Jiang, Hong
    Li, Jing
    Bai, Xuefan
    Lian, Jianqi
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
12345